Menu

Search

Paul Aveyard

Paul Aveyard

Professor of Behavioural Medicine, University of Oxford
My research focuses on behavioural medicine. This is the integration of biological, psychological and sociological knowledge to prevent and treat disease and to aid rehabilitation. You can read more about our research on our team website here https://www.phc.ox.ac.uk/research/research-themes/health-behaviours-theme.

My work focuses on helping people change their behaviour, either to prevent serious disease, or as a treatment for that disease.

A lot of my work has examined interventions to help people stop or reduce their smoking and lately I have worked in helping people manage their weight if they have become obese.

People often use several drugs to help them stop smoking but our research suggested that combining these drugs does not help more than taking only one of them. Our research has shown that people who stop smoking put on a considerable amount of weight and we are investigating the best ways to prevent this weight gain but without harming the chance of stopping smoking.

One of our trials showed that people who were referred to commercial weight management providers lost more weight than people who tried to lose weight without support. However, people who went to their GP or practice nurse for support did no better than people trying without support. This result helped change government policy and local health organisations now contract with commercial weight providers. We have also shown that a brief 30-second behavioural intervention delivered by a clinician opportunistically can motivate a person to take up effective support and lose weight. Such brief interventions were highly acceptable to patients and easy for clinicians to deliver.

I work with several other organisations to improve health and healthcare. I am former president of the UK Society of Behavioural Medicine, a former trustee of the Association for the Study of Obesity, a member of the Society for Research on Nicotine and Tobacco. I am a senior editor of the journal Addiction and coordinating editor of the Cochrane Tobacco Addiction Group. I have worked on several NICE working groups and advised the Department of Health and NHS England on smoking and obesity.

I try to make my publications available to everyone. Please have a look for them here https://ora.ox.ac.uk/ or on researchgate.net.

I am an NIHR senior investigator.

1 

Economy

Dollar Set for Fourth Weekly Loss as Tariff Worries and Safe-Haven Demand Grow

The U.S. dollar is poised for its fourth straight weekly loss as investor concerns over tariffs and trade uncertainty drive a shift away from U.S. assets. Despite a slight rebound from a seven-month low against the yen,...

Bank of Korea Holds Rates Amid Trade Tariff Threats and Weakening Won

South Koreas central bank kept its key interest rate steady at 2.75% on Thursday, aiming to stabilize the Korean won as global trade tensions escalate. The decision by the Bank of Korea (BOK) aligns with expectations from...

Singapore’s March Exports Rise 5.4% Amid Tariff Concerns and Growth Forecast Cut

Singapores non-oil domestic exports (NODX) rose 5.4% year-on-year in March, according to Enterprise Singapore data released Thursday. The increase was driven by gains in both electronics and non-electronic shipments....

BOJ to Cut Growth Outlook Amid Trump Tariff Risks

The Bank of Japan (BOJ) is expected to lower its economic growth forecast at its upcoming April 30May 1 policy meeting, as escalating tariff risks from U.S. President Donald Trump threaten Japans export-driven recovery....

China and Japan Boost U.S. Treasury Holdings Despite Tariff Tensions

Speculation that China and Japan were dumping U.S. Treasuries was challenged on Wednesday after the U.S. Treasury Department reported a 3.4% rise in foreign holdings of Treasuries in February, reaching $8.82 trillion....

Politics

Trump Aides in Paris for Ukraine Ceasefire, Iran Nuclear Talks

Two top U.S. national security officialsSecretary of State Marco Rubio and special envoy Steve Witkoffare set to meet French President Emmanuel Macron in Paris on Thursday, aiming to align U.S. and European efforts on...

U.S.-France Talks to Focus on Ukraine, Iran, and Middle East Tensions

U.S. Secretary of State Marco Rubio will meet with French Foreign Minister Jean-Noel Barrot in Paris on Thursday to discuss key global issues including the war in Ukraine, Irans nuclear program, and tensions in the Middle...

Ukraine and U.S. Near Minerals Deal Amid Progress in Bilateral Talks

Ukraine and the United States are nearing the signing of a memorandum of understanding (MoU) on a minerals agreement, signaling substantial progress in bilateral talks, according to Ukraines First Deputy Prime Minister...

Macron Vows Justice as French Prisons Face Wave of Attacks

French President Emmanuel Macron pledged swift justice following a third consecutive night of violent attacks targeting prisons across France. At least nine correctional facilities and related institutions, including a...

U.S. Senator Denied Access to Deported Salvadoran Held in Notorious Prison

U.S. Senator Chris Van Hollen (D-MD) was denied access to Kilmar Abrego Garcia, a Salvadoran man mistakenly deported from the United States, during a diplomatic visit to El Salvador. Abrego Garcia, who lived in Maryland,...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Tencent, Douyin Launch Domestic Sales Initiatives Amid U.S.-China Trade Tensions

Chinese tech giants Tencent and Douyin, TikToks sister app in China, have launched new initiatives to support local exporters affected by the intensifying U.S.-China trade war. These efforts aim to help export-reliant...

Stargate AI Megaproject Eyes UK Expansion Backed by OpenAI, SoftBank, Oracle

The $500 billion Stargate data center project, backed by OpenAI, SoftBank (TYO:9984), and Oracle (NYSE:ORCL), is exploring expansion opportunities in the UK as it seeks overseas sites for scaling artificial intelligence...

U.S. Imposes New Export Curbs on Nvidia and AMD AI Chips to China

The U.S. Commerce Department announced new export licensing requirements on Tuesday targeting Nvidias H20 and AMDs MI308 artificial intelligence chips, along with equivalent models, restricting their shipment to China. The...

NVIDIA Stock Dips on $5.5B Hit From China Export Controls

NVIDIA (NASDAQ:NVDA) shares fell 6% in after-hours trading to $105.42 after the company announced it expects up to $5.5 billion in charges related to U.S. export restrictions on its AI chips to China. The charges will be...

Japan Orders Google to Halt Anticompetitive Smartphone Practices

Japans Fair Trade Commission (JFTC) has issued a cease and desist order to Google (NASDAQ: GOOGL) for engaging in anticompetitive practices, marking the countrys first formal crackdown on a U.S. tech giant for market...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.